Dear Editor, Regarding the recent report by Patil and colleagues about sarcopenia and osteopenia prevalence [1] , we would like to address some methodological issues. It is stated that the prevalence of sarcopenia using the European Working Group on Sarcopenia in Older People (EWGSOP) is 0.9 %. This is grossly out of other frequencies reported using the same algorithm, which is over 30 %. The first report by Landi and colleagues showed a prevalence of 32.8 % in a group of institutionalized elderly (n0122), while our group reported 33.6 % in an ambulatory sample of 70 years or older subjects (n0345) [2, 3] . The first report included all the residents of the nursing home where the study was performed, while our study used a representative sample of Mexico City. However, the sample of Patil et al. was derived from an intervention study, in which neither the whole population (n09,370) nor a representative sample was used. Although an excellent sample of a study was aimed to have internal validity, external validity represented by prevalence could be misleading [4] . Nevertheless, other factors could contribute to different frequencies of sarcopenia, like those already pointed by the authors: lack of precise diagnostic criteria and unavailability of standard reference data to the components of the EWGSOP algorithm [1, 5] .
